🇺🇸 Dexamethasone 12 mg in United States

22 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Infusion Related Reaction — 5 reports (22.73%)
  2. Chest Discomfort — 3 reports (13.64%)
  3. Dyspnoea — 3 reports (13.64%)
  4. Erythema — 3 reports (13.64%)
  5. Back Pain — 2 reports (9.09%)
  6. Pruritus — 2 reports (9.09%)
  7. Abdominal Discomfort — 1 report (4.55%)
  8. Anaphylactic Reaction — 1 report (4.55%)
  9. Angioedema — 1 report (4.55%)
  10. Atrial Fibrillation — 1 report (4.55%)

Source database →

Dexamethasone 12 mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Dexamethasone 12 mg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Dexamethasone 12 mg in United States?

Zealand University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.